CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+16%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$70.4K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
244
Closed
13
Top Buys
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.28M |
| 2 |
Tesla
TSLA
|
$2.24M |
| 3 |
Apple
AAPL
|
$2.14M |
| 4 |
Meta Platforms (Facebook)
META
|
$2.1M |
| 5 |
Vaxcyte
PCVX
|
$2M |
Top Sells
| 1 |
iQIYI
IQ
|
$4.85M |
| 2 |
Amazon
AMZN
|
$4.7M |
| 3 |
Airbnb
ABNB
|
$3.2M |
| 4 |
Analog Devices
ADI
|
$2.94M |
| 5 |
KE Holdings
BEKE
|
$1.93M |
Sector Composition
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pacific Biosciences
PACB
$381M
| $227K | 0.07% |
17,078
-73
| -0.4% | -$971 |
|
127
uniQure
QURE
$985M
| $218K | 0.07% |
19,060
-13
| -0.1% | -$149 |
|
128
Apellis Pharmaceuticals
APLS
$3.55B
| $213K | 0.07% |
2,341
-25
| -1% | -$2.28K |
|
129
Sanofi
SNY
$113B
| $211K | 0.07% |
3,917
-109
| -3% | -$5.88K |
|
130
Comcast
CMCSA
$125B
| $195K | 0.06% |
4,694
+3,422
| +269% | +$142K |
|
131
T-Mobile US
TMUS
$284B
| $188K | 0.06% |
1,354
+985
| +267% | +$137K |
|
132
Zoom
ZM
$25B
| $185K | 0.06% |
2,723
+209
| +8% | +$14.2K |
|
133
Texas Instruments
TXN
$171B
| $184K | 0.06% |
1,024
+750
| +274% | +$135K |
|
134
Incyte
INCY
$16.9B
| $182K | 0.06% |
2,925
-96
| -3% | -$5.98K |
|
135
Royalty Pharma
RPRX
$15.6B
| $181K | 0.06% |
5,874
-131
| -2% | -$4.03K |
|
136
Zoetis
ZTS
$67.9B
| $170K | 0.05% |
986
| – | – |
|
|
DDL
137
Dingdong
DDL
$470M
| $165K | 0.05% |
53,514
| – | – |
|
138
Intel
INTC
$107B
| $157K | 0.05% |
4,707
+3,456
| +276% | +$116K |
|
139
Viatris
VTRS
$12.2B
| $157K | 0.05% |
15,715
-501
| -3% | -$5K |
|
140
Honeywell
HON
$136B
| $156K | 0.05% |
751
+549
| +272% | +$114K |
|
141
argenx
ARGX
$45.9B
| $152K | 0.05% |
391
-10
| -2% | -$3.9K |
|
142
Intuit
INTU
$188B
| $145K | 0.04% |
316
+231
| +272% | +$106K |
|
143
Sarepta Therapeutics
SRPT
$1.96B
| $140K | 0.04% |
1,221
+29
| +2% | +$3.32K |
|
144
Yum! Brands
YUM
$40.1B
| $137K | 0.04% |
992
| – | – |
|
145
Applied Materials
AMAT
$130B
| $137K | 0.04% |
948
+692
| +270% | +$100K |
|
146
United Therapeutics
UTHR
$18.1B
| $136K | 0.04% |
615
-13
| -2% | -$2.87K |
|
147
Neurocrine Biosciences
NBIX
$14.3B
| $121K | 0.04% |
1,279
-30
| -2% | -$2.83K |
|
148
Mondelez International
MDLZ
$79.9B
| $113K | 0.03% |
1,537
+1,125
| +273% | +$82.4K |
|
|
KRTX
149
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $106K | 0.03% |
490
+22
| +5% | +$4.77K |
|
150
Capri Holdings
CPRI
$2.53B
| $105K | 0.03% |
2,928
-8,586
| -75% | -$308K |
|